NICE 'must listen to patients' on schizophrenia guidelines

Campaigners have challenged the National Institute for Clinical Excellence not to ignore the views of people with mental health problems in its forthcoming schizophrenia treatment guidelines and assessment of antipsychotic drugs.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here